Utilization of an Industry Byproduct, <i>Corymbia maculata</i> Leaves, by <i>Aspergillus terreus</i> to Produce Lovastatin

Due to its ability to lower cholesterol levels, simvastatin is a leading drug for the prevention of strokes and heart disease: it also lowers the incidence of neurodegenerative diseases. Simvastatin is made from lovastatin, a precursor produced by the industrial fungus, <i>Aspergillus terreus&...

Full description

Bibliographic Details
Main Authors: Mishal Subhan, Rani Faryal, Ian Macreadie
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Bioengineering
Subjects:
Online Access:https://www.mdpi.com/2306-5354/7/3/101
_version_ 1827707242439245824
author Mishal Subhan
Rani Faryal
Ian Macreadie
author_facet Mishal Subhan
Rani Faryal
Ian Macreadie
author_sort Mishal Subhan
collection DOAJ
description Due to its ability to lower cholesterol levels, simvastatin is a leading drug for the prevention of strokes and heart disease: it also lowers the incidence of neurodegenerative diseases. Simvastatin is made from lovastatin, a precursor produced by the industrial fungus, <i>Aspergillus terreus</i>. In this study, <i>Corymbia maculata</i> leaves were tested as a novel substrate for the growth of a new isolate of <i>A. terreus</i> and a lovastatin-resistant strain of <i>A. terreus</i> to produce lovastatin. <i>Corymbia maculata</i> (spotted gum) is well utilized by forest industries as a source of timber because of its high strength, durability and smooth texture. However, the leaves are a major waste product. Growth of <i>A. terreus</i> on <i>Corymbia maculata</i> leaves, in solid-state fermentation resulted in the production of lovastatin. Fermentation of media using fresh leaves of <i>Corymbia maculata</i> produced more lovastatin (4.9 mg g<sup>−1</sup>), than the sun-dried leaves (3.2 mg g<sup>−1</sup>). Levels of lovastatin were further increased by the lovastatin-resistant strain of <i>A. terreus</i> (Lvs-r), which produced twice the amount of the parental strain. The production of lovastatin was confirmed by HPLC and LC–MS/MS studies. The study suggests that the utilization of a cheap substrate for the production of lovastatin can have a potential economic benefit.
first_indexed 2024-03-10T16:42:57Z
format Article
id doaj.art-78b7f4ea21c54e0681080d6fe7653ca5
institution Directory Open Access Journal
issn 2306-5354
language English
last_indexed 2024-03-10T16:42:57Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Bioengineering
spelling doaj.art-78b7f4ea21c54e0681080d6fe7653ca52023-11-20T11:52:55ZengMDPI AGBioengineering2306-53542020-08-017310110.3390/bioengineering7030101Utilization of an Industry Byproduct, <i>Corymbia maculata</i> Leaves, by <i>Aspergillus terreus</i> to Produce LovastatinMishal Subhan0Rani Faryal1Ian Macreadie2Department of Microbiology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, PakistanDepartment of Microbiology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, PakistanSchool of Science, RMIT University, Bundoora, VIC 3083, AustraliaDue to its ability to lower cholesterol levels, simvastatin is a leading drug for the prevention of strokes and heart disease: it also lowers the incidence of neurodegenerative diseases. Simvastatin is made from lovastatin, a precursor produced by the industrial fungus, <i>Aspergillus terreus</i>. In this study, <i>Corymbia maculata</i> leaves were tested as a novel substrate for the growth of a new isolate of <i>A. terreus</i> and a lovastatin-resistant strain of <i>A. terreus</i> to produce lovastatin. <i>Corymbia maculata</i> (spotted gum) is well utilized by forest industries as a source of timber because of its high strength, durability and smooth texture. However, the leaves are a major waste product. Growth of <i>A. terreus</i> on <i>Corymbia maculata</i> leaves, in solid-state fermentation resulted in the production of lovastatin. Fermentation of media using fresh leaves of <i>Corymbia maculata</i> produced more lovastatin (4.9 mg g<sup>−1</sup>), than the sun-dried leaves (3.2 mg g<sup>−1</sup>). Levels of lovastatin were further increased by the lovastatin-resistant strain of <i>A. terreus</i> (Lvs-r), which produced twice the amount of the parental strain. The production of lovastatin was confirmed by HPLC and LC–MS/MS studies. The study suggests that the utilization of a cheap substrate for the production of lovastatin can have a potential economic benefit.https://www.mdpi.com/2306-5354/7/3/101<i>Aspergillus terreus</i>eucalyptusfermentationlovastatinSmFSSF
spellingShingle Mishal Subhan
Rani Faryal
Ian Macreadie
Utilization of an Industry Byproduct, <i>Corymbia maculata</i> Leaves, by <i>Aspergillus terreus</i> to Produce Lovastatin
Bioengineering
<i>Aspergillus terreus</i>
eucalyptus
fermentation
lovastatin
SmF
SSF
title Utilization of an Industry Byproduct, <i>Corymbia maculata</i> Leaves, by <i>Aspergillus terreus</i> to Produce Lovastatin
title_full Utilization of an Industry Byproduct, <i>Corymbia maculata</i> Leaves, by <i>Aspergillus terreus</i> to Produce Lovastatin
title_fullStr Utilization of an Industry Byproduct, <i>Corymbia maculata</i> Leaves, by <i>Aspergillus terreus</i> to Produce Lovastatin
title_full_unstemmed Utilization of an Industry Byproduct, <i>Corymbia maculata</i> Leaves, by <i>Aspergillus terreus</i> to Produce Lovastatin
title_short Utilization of an Industry Byproduct, <i>Corymbia maculata</i> Leaves, by <i>Aspergillus terreus</i> to Produce Lovastatin
title_sort utilization of an industry byproduct i corymbia maculata i leaves by i aspergillus terreus i to produce lovastatin
topic <i>Aspergillus terreus</i>
eucalyptus
fermentation
lovastatin
SmF
SSF
url https://www.mdpi.com/2306-5354/7/3/101
work_keys_str_mv AT mishalsubhan utilizationofanindustrybyproducticorymbiamaculataileavesbyiaspergillusterreusitoproducelovastatin
AT ranifaryal utilizationofanindustrybyproducticorymbiamaculataileavesbyiaspergillusterreusitoproducelovastatin
AT ianmacreadie utilizationofanindustrybyproducticorymbiamaculataileavesbyiaspergillusterreusitoproducelovastatin